Hausse des IST : L’OMS presse les gouvernements de renforcer la surveillance de la gonorrhée
New data published by the World Health Organization (WHO), from the Expanded Programme on Antimicrobial Resistance Surveillance (EGASP), reveal an alarming increase in gonorrhea resistance to antibiotic treatments. This sexually transmitted infection (STI), already widespread, is becoming increasingly difficult to treat, threatening public health gains.
The publication of these results coincides with World Antimicrobial Resistance Awareness Week, dedicated to raising awareness and combating drug-resistant infections. Launched in 2015, the EGASP (European Global Antimicrobial Stewardship Program) enables the WHO to collect clinical and laboratory data from sentinel sites worldwide in order to adapt treatment guidelines.
“This work of global scope is essential for monitoring, preventing, and treating drug-resistant gonorrhea, and for protecting public health worldwide,” emphasizes the Director of the WHO Department of HIV, Tuberculosis, Hepatitis and STIs. Dr. Tereza Kasaeva adds: “WHO calls on all countries to address the rise in STI cases and to integrate gonorrhea surveillance into national STI programs.”
Resistance levels rising sharply
Between 2022 and 2024, resistance levels to the main antibiotics used against gonorrhea increased significantly: resistance to ceftriaxone rose from 0.8% to 5%, to cefixime from 1.7% to 11%, resistance to azithromycin remained stable at 4%, and resistance to ciprofloxacin now reaches 95%. Cambodia and Vietnam are among the countries with the highest rates.
In 2024, twelve countries submitted data to the WHO, compared to only four in 2022, a significant increase demonstrating a growing commitment to surveillance and the fight against drug-resistant STIs. A total of 3,615 cases of gonorrhea were reported in these countries.
Patient profile and geographical distribution
More than half of symptomatic gonorrhea cases in men (52%) originate from the Western Pacific Region: Philippines (28%), Viet Nam (12%), Cambodia (9%), Indonesia (3%). These are followed by countries in the African Region (28%), Thailand (13%), Qatar (4%), and Brazil (2%).
The median age of patients is 27 years, with a range from 12 to 94 years. Among those diagnosed, 20% are men who have sex with men, 42% report having had multiple partners in the past 30 days, 8% have recently used antibiotics, and 19% have traveled.
In 2024, nearly 3,000 samples were sequenced in eight countries to improve genomic surveillance. Simultaneously, clinical trials of promising new molecules, zoliflodacin and gepotidacin, progressed, paving the way for more effective treatments in the future. The EGASP Programme continues to expand: Brazil, Côte d'Ivoire, and Qatar joined in 2024, while India will publish its first data in 2025 as part of its national STI control program.
Persistent challenges
Despite these advances, obstacles remain: insufficient funding, incomplete data in several countries, and a lack of information concerning women and extragenital sites. The WHO therefore calls on states to urgently invest in their surveillance systems to strengthen the global response to antimicrobial-resistant gonorrhea.
Commentaires (5)
trop de fornicateurs
Arrêter la polygamie et le multipartenariat et tout ira pour le mieux du monde.
chonkoesque
J’ai chopé cette merde dans un salon de massage suite à une riko.heureusement une fois de retour au pays des blancs je l’ai traité en une semaine
Éviter les filles et rester fidèle car une erreur irréparable peut vite arriver juste pour quelques secondes de plaisir .
Au Sénégal la plupart des filles et garçons sont actifs sexuellement et ne se protègent pas lors des rapports sexuelles laissent une place aux mst et ist
Vite fermez Sweet Beauty.
Ndeye Khady ne perdra rien car elle est dans le busines d'armement maintenant.
Participer à la Discussion